News

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...